Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 40, Issue 9 (Sep 2002)

Issues

Protein Expression in Mycobacterium tuberculosis Differs with Growth Stage and Strain Type

Carmen Pheiffer / Joanna Betts / Pauline Lukey / Paul van Helden
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2002.154

Abstract

Different phenotypes are displayed by Mycobacterium tuberculosis (M. tuberculosis) strains, fuelling speculation that certain strains are “hypervirulent” and able to evade host defenses better than others. Furthermore, differential antigen expression by M. tuberculosis strains may explain why certain patients are susceptible to a repeat episode of tuberculosis. The objective of this study was to compare protein expression by M. tuberculosis H37Rv and clinical isolates in order to determine whether differential protein expression contributes to the different phenotypes expressed by these strains. Expression of α-crystallin, the antigen 85 complex, PstS-1, L-alanine dehydrogenase and the 65 kDa antigen was analysed by Western blotting and enzyme-linked immunosorbent assays, using mouse monoclonal antibodies. We found no significant difference in the growth rate of the M. tuberculosis strains in vitro, and although M. tuberculosis protein expression showed phase variation during growth, expression seemed to be qualitatively, but not quantitatively, conserved in the strains investigated. These results have potentially important implications for vaccine development and serodiagnosis.

About the article

Published Online: 2005-06-01

Published in Print: 2002-09-24


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2002.154.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Cecilia S. Lindestam Arlehamn, Anna Gerasimova, Federico Mele, Ryan Henderson, Justine Swann, Jason A. Greenbaum, Yohan Kim, John Sidney, Eddie A. James, Randy Taplitz, Denise M. McKinney, William W. Kwok, Howard Grey, Federica Sallusto, Bjoern Peters, Alessandro Sette, and Padmini Salgame
PLoS Pathogens, 2013, Volume 9, Number 1, Page e1003130
[2]
Nicole A. Kruh-Garcia, Madeleine Murray, John G. Prucha, and Karen M. Dobos
Journal of Proteomics, 2014, Volume 97, Page 141
[3]
S. Kunnath-Velayudhan, H. Salamon, H.-Y. Wang, A. L. Davidow, D. M. Molina, V. T. Huynh, D. M. Cirillo, G. Michel, E. A. Talbot, M. D. Perkins, P. L. Felgner, X. Liang, and M. L. Gennaro
Proceedings of the National Academy of Sciences, 2010, Volume 107, Number 33, Page 14703

Comments (0)

Please log in or register to comment.
Log in